/IMCC
IMCC Stock - IM Cannabis Corp.
Healthcare|Drug Manufacturers - Specialty & GenericNASDAQ
$1.39+0.16%
+$0.00 (+0.16%) • Jan 13
44
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.6
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.40
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.53
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IMCC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.38 – $1.41
TARGET (TP)$1.60
STOP LOSS$1.28
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.99
52W High$7.12
52W Low$0.93
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $54.03M | $48.80M | $54.34M | $34.05M | $15.89M |
| Gross Profit | $8.45M | $9.85M | $9.16M | $6.33M | $10.47M |
| Gross Margin | 15.6% | 20.2% | 16.9% | 18.6% | 65.9% |
| Operating Income | $-10,234,000 | $-12,792,000 | $-30,791,000 | $-23,035,000 | $-8,245,000 |
| Net Income | $-10,585,000 | $-9,498,000 | $-188,890,000 | $-17,763,000 | $-28,698,000 |
| Net Margin | -19.6% | -19.5% | -347.6% | -52.2% | -180.6% |
| EPS | $-4.51 | $-4.45 | $-76.80 | $-5.71 | $-7.45 |
Company Overview
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
IMCCBeat Rate
44%
Last 18 quarters
Avg Surprise
-342.4%
EPS vs Estimate
Beats / Misses
8/9
1 met exactly
Latest EPS
$-0.54
Q4 2025
EPS Surprise History
Q1 24
-12.5%
$-1.08vs$-0.96
Q2 24
0.0%
$-0.96vs$-0.96
Q3 24
+79.8%
$-0.17vs$-0.84
Q4 24
+57.1%
$-0.30vs$-0.70
Q1 25
+41.0%
$-0.23vs$-0.39
Q2 25
+123.6%
$0.06vs$-0.25
Q3 25
+48.8%
$-0.07vs$-0.14
Q4 25
-2234.6%
$-0.54vs$-0.02
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | $-0.02 | $-0.54 | -2234.6% | ✗ MISS |
Q3 2025 | Aug 12, 2025 | $-0.14 | $-0.07 | +48.8% | ✓ BEAT |
Q2 2025 | May 15, 2025 | $-0.25 | $0.06 | +123.6% | ✓ BEAT |
Q1 2025 | Mar 31, 2025 | $-0.39 | $-0.23 | +41.0% | ✓ BEAT |
Q4 2024 | Nov 14, 2024 | $-0.70 | $-0.30 | +57.1% | ✓ BEAT |
Q3 2024 | Aug 14, 2024 | $-0.84 | $-0.17 | +79.8% | ✓ BEAT |
Q2 2024 | May 8, 2024 | $-0.96 | $-0.96 | 0.0% | = MET |
Q1 2024 | Mar 28, 2024 | $-0.96 | $-1.08 | -12.5% | ✗ MISS |
Q4 2023 | Nov 13, 2023 | $-0.96 | $-0.72 | +25.0% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-0.78 | $-1.14 | -46.2% | ✗ MISS |
Q2 2023 | May 15, 2023 | $-1.20 | $0.12 | +110.0% | ✓ BEAT |
Q1 2023 | Mar 29, 2023 | $-0.28 | $-1.32 | -371.4% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-3.60 | $-3.00 | +16.7% | ✓ BEAT |
Q3 2022 | Aug 15, 2022 | $-1.80 | $-14.40 | -700.0% | ✗ MISS |
Q2 2022 | May 12, 2022 | $-1.20 | $-7.80 | -550.0% | ✗ MISS |
Q1 2022 | Mar 31, 2022 | $-1.80 | $-9.00 | -400.0% | ✗ MISS |
Q4 2021 | Nov 24, 2021 | $-0.60 | $-8.40 | -1300.0% | ✗ MISS |
Q3 2021 | Aug 16, 2021 | $-0.20 | $-2.30 | -1050.0% | ✗ MISS |
Q2 2021 | May 18, 2021 | — | $-0.60 | — | — |
Latest News
'New Hampshire House Passes Bills To Legalize Marijuana And Let Dispensaries Convert To For-Profit Status' - Marijuana Moment
📈 PositiveBenzinga•Jan 7, 2026, 03:48 PM•Also: , ,
'Congressional Leaders Drop Attempt To Block Marijuana Rescheduling, While Preserving State Medical Cannabis Protections'- Marijuana Moment
📈 PositiveBenzinga•Jan 5, 2026, 07:51 PM•Also: , ,
'Florida Attorney General Asks Supreme Court To Block Marijuana Legalization Measure From Ballot' - Marijuana Moment
📉 NegativeBenzinga•Jan 5, 2026, 04:52 PM•Also: , ,
IM Cannabis Said It Is Evaluating Certain Strategic Opportunities To Expand Its Operations Into The United States Cannabis Market Following President Trump's Executive Order
📈 PositiveBenzinga•Dec 30, 2025, 12:43 PM
'Federal Health Programs Will Cover Up To $500 Worth Of CBD For Certain Patients By April, Trump Official Dr. Oz Says'- Marijuana Moment
📈 PositiveBenzinga•Dec 24, 2025, 03:49 PM•Also: , ,
'President Trump Directs Attorney General Pam Bondi to Finalize Marijuana Rescheduling by the End of January'- The Marijuana Herald
➖ NeutralBenzinga•Dec 23, 2025, 07:55 PM•Also: , ,
'Supreme Court Should Uphold Gun Ban For Marijuana Users, 19 State AGs Tell Justices' - Marijuana Moment
➖ NeutralBenzinga•Dec 23, 2025, 05:18 PM•Also: , ,
'Trump's Marijuana Executive Order Details Leaked Ahead Of Announcement, Including CBD And Hemp Provisions'- Marijuana Moment
📈 PositiveBenzinga•Dec 18, 2025, 05:50 PM•Also: , ,
'Trump's Marijuana Rescheduling Order Could Include Industry Banking And CBD Medicare Coverage Provisions, Sources Say;'- Marijuana Moment
📈 PositiveBenzinga•Dec 17, 2025, 05:01 PM•Also: , ,
Shares of cannabis-linked stocks are trading higher following reports suggesting President Trump will sign an executive order that will reclassify marijuana to a Schedule III drug.
📈 PositiveBenzinga•Dec 17, 2025, 02:38 PM•Also: , ,
'Trump Expected To Sign An Order Moving To Reclassify Cannabis And Open Up Medical Potential' - NBC News
📈 PositiveBenzinga•Dec 17, 2025, 09:12 AM•Also: , ,
Shares of cannabis-linked stocks are trading higher after President Donald Trump confirmed his administration is strongly considering reclassifying marijuana.
📈 PositiveBenzinga•Dec 16, 2025, 07:17 PM•Also: , ,
Liz Claman Posts On X "ALERT: Word is a @realDonaldTrump executive order to reclassify cannabis/marijuana as less dangerous, less regulated Class III substance
📈 PositiveBenzinga•Dec 15, 2025, 08:48 PM•Also: , ,
President Trump Says Considering Executive Oder To Reclassify Marijuana
➖ NeutralBenzinga•Dec 15, 2025, 08:45 PM•Also: , ,
IM Cannabis Appoints Asi Levi As CFO; Succeeds Uri Birenberg
➖ NeutralBenzinga•Dec 12, 2025, 09:02 PM
Shares of cannabis-linked stocks are trading higher following a report suggesting that President Trump is expected to reclassify marijuana as a Schedule III drug.
📈 PositiveBenzinga•Dec 12, 2025, 01:23 PM•Also: , ,
'Nebraska Supreme Court Hears Case Seeking To Overturn Medical Marijuana Law Approved By Voters' - Marijuana Moment
➖ NeutralBenzinga•Dec 4, 2025, 01:59 PM•Also: , ,
UPDATE: 'Medicare to Test Making CBD Treatment Available for Seniors' - Bloomberg News
📈 PositiveBenzinga•Nov 26, 2025, 05:58 PM•Also: , ,
'Marijuana Banking Bill Is 'On The Back Burner,' As Congressional Lawmakers See No Indication It'll Advance Soon' - Marijuana Moment
📉 NegativeBenzinga•Nov 25, 2025, 03:27 PM•Also: , ,
'GOP Representative Brian Mast Signs On As Sponsor Of Bipartisan Legislation To Reschedule Cannabis' - Marijuana Herald
📈 PositiveBenzinga•Nov 24, 2025, 04:19 PM•Also: , ,
Frequently Asked Questions about IMCC
What is IMCC's current stock price?
IM Cannabis Corp. (IMCC) is currently trading at $1.39 per share. The stock has moved +0.16% today.
What is the analyst price target for IMCC?
No analyst price targets are currently available for this stock.
What sector is IM Cannabis Corp. in?
IM Cannabis Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the NASDAQ exchange.
What is IMCC's market cap?
IM Cannabis Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does IMCC pay dividends?
No, IM Cannabis Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAKAN
Akanda Corp.
$2.06
Mkt Cap: $0.0B
FLGC
Flora Growth Corp.
$6.57
Mkt Cap: $0.0B
GRI
GRI Bio, Inc.
$0.22
Mkt Cap: $0.0B
JAGX
Jaguar Health, Inc.
$0.70
Mkt Cap: $0.0B
MOVE
Movano Inc.
$6.94
Mkt Cap: $0.0B
NAOV
NanoVibronix, Inc.
$2.28
Mkt Cap: $0.0B
NDRA
ENDRA Life Sciences Inc.
$4.47
Mkt Cap: $0.0B
RDHL
RedHill Biopharma Ltd.
$1.21
Mkt Cap: $0.0B
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$1.44
Mkt Cap: $0.0B
VERO
Venus Concept Inc.
$1.41
Mkt Cap: $0.0B
Explore stocks similar to IMCC for comparison